ImmunoGen Inc
(NASDAQ: IMGN)
-0.17-0.99%Today's Close
|
17.27
+0.24
+1.38%
After hours
ImmunoGen Inc, a small-cap growth company in the health care sector, is expected to outperform the market over the next six months with above average risk.
10 is the best possible rating.
The StockScouter measure of relative price change and consistency is very high. Very positive
The most recent quarterly earnings report was much higher than analysts’ consensus forecast. Positive
ConThe price-to-earnings multiple is a negative number. No effect
One or more analysts has significantly decreased quarterly earnings estimates for IMGN. Negative
The most recent quarterly earnings report was much higher than analysts’ consensus forecast. Positive
Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
One or more analysts has significantly decreased quarterly earnings estimates for IMGN. Negative
An executive, director or major shareholder sold a small number of shares recently. Neutral
Institutional holdings information is unavailable or inconsistent.
The price-to-earnings multiple is a negative number. No effect
Price-to-sales information is unavailable or inconsistent.
The ratio of IMGN's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is very high. Very positive
Previous day's closing price for IMGN was slightly above its 50-day moving average. Positive
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/22/2013 4:41 PM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
